A BIOPHARMA company founded by the American presidential hopeful Vivek Ramaswamy has sold its bowel-disease drug development arm to the Swiss group Roche. Roivant Sciences will get $7.1 billion upfront…
Subscribe for our weekly news letter here!
You can unsubscribe us at any time